https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00389-2/fulltext
0
0
12/5/22 at 11:33pm
Organization
The Lancet
81 words
0
Comments
Our findings underline the importance of continued SARS-CoV-2 vaccination programmes,
including second-generation bivalent vaccines, especially in patient subgroups where
vaccine immunogenicity and efficacy might be reduced, such as those on anti-TNF therapie…
You are the first to view
Create an account
or login to join the discussion